BioLineRx
(NASDAQ) BLRX
BioLineRx Financials at a Glance
Market Cap
$9.96M
Revenue (TTM)
$1.18M
Net Income (TTM)
$1.18M
EPS (TTM)
$-0.18
P/E Ratio
-12.65
Dividend
$0.00
Beta (Volatility)
0.79 (Low)
Dividend
$0.00
Beta (Volatility)
0.79 (Low)
Price
$2.33
Volume
100
Open
$2.33
Price
$2.33
Volume
100
Open
$2.33
Previous Close
$2.33
Daily Range
$2.33 - $2.33
52-Week Range
$2.15 - $7.77
Dividend
$0.00
Beta (Volatility)
0.79 (Low)
Price
$2.33
Volume
100
Open
$2.33
Previous Close
$2.33
Daily Range
$2.33 - $2.33
52-Week Range
$2.15 - $7.77
BLRX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout BioLineRx
Industry
Biotechnology
Sector
Health CareEmployees
24
CEO
Philip Adam Serlin, MBA, CPA
Website
www.biolinerx.comHeadquarters
Hevel Modi'in, 7177871, IL
BLRX Financials
Key Financial Metrics (TTM)
Gross Margin
75%
Operating Margin
-9%
Net Income Margin
-1%
Return on Equity
-8%
Return on Capital
-36%
Return on Assets
-3%
Earnings Yield
-7.91%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$9.96M
Shares Outstanding
4.35M
Volume
100
Short Interest
0.00%
Avg. Volume
14.95K
Financials (TTM)
Gross Profit
$430.39K
Operating Income
$10.37M
EBITDA
$9.84M
Operating Cash Flow
$8.14M
Capital Expenditure
$25.20K
Free Cash Flow
$8.16M
Cash & ST Invst.
$20.88M
Total Debt
$10.15M
BioLineRx Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$195.21K
-98.3%
Gross Profit
$91.57K
-98.4%
Gross Margin
46.91%
N/A
Market Cap
$9.96M
N/A
Market Cap/Employee
$355.88K
N/A
Employees
28
N/A
Net Income
$1.39M
+56.3%
EBITDA
$3.34M
-207.9%
Quarterly Fundamentals
Net Cash
$10.73M
+137.2%
Accounts Receivable
$455.99K
-88.2%
Inventory
$2.15M
-31.7%
Long Term Debt
$5.44M
-45.8%
Short Term Debt
$4.71M
-5.8%
Return on Assets
-2.94%
N/A
Return on Invested Capital
-35.98%
N/A
Free Cash Flow
$3.25M
+62.2%
Operating Cash Flow
$3.23M
+62.5%